Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Income from Non-Controlling Interests came in at -$304000.0 in Q2 2025, up 87.88% year-over-year from -$161806.5 in Q2 2024, and up 13.88% quarter-over-quarter from -$353000.0 in Q1 2025.
Analysis
Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Income from Non-Controlling Interests for 4 consecutive years, with -$304000.0 the latest figure, recorded in Q2 2025.
- On a quarterly basis, Income from Non-Controlling Interests rose 87.88% year-over-year to -$304000.0 in Q2 2025; TTM through Jun 2025 was -$2.3 million, a 89.97% increase from a year earlier, with the FY2024 full-year figure at $3.3 million, down 65.27% from the prior year.
- Income from Non-Controlling Interests was -$304000.0 for Q2 2025 at Vicarious Surgical, up from -$353000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $892000.0 in Q1 2024 and troughed at -$21.0 million in Q2 2021.
- A 3-year average of -$4.7 million and a median of -$353000.0 in 2025 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests slumped 78652.22% in 2021 and surged 87.88% in 2025, its largest moves.
- Over 3 years, Income from Non-Controlling Interests stood at -$21.0 million in 2021, then surged by 88.07% to -$2.5 million in 2024, then surged by 87.88% to -$304000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$304000.0 (Q2 2025), -$353000.0 (Q1 2025), and -$2.5 million (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 900,000.00 |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -304,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Jun 30, 2024 | -2.51 Mn |
| Mar 31, 2024 | 892,000.00 |
| Jun 30, 2021 | -21.03 Mn |
| Jun 30, 2020 | -26,704.00 |